Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL
- 24 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 25 (9), 1452-1458
- https://doi.org/10.1038/leu.2011.111
Abstract
Chronic lymphocytic leukemia (CLL) cells require complex microenvironmental and immunologic interactions to survive and proliferate. Such interactions might be best recreated in animal models; however, this needs extensive verification. We therefore investigated the composition of the T-cell compartment in the Eμ-TCL1 transgenic mouse, currently the most widely used murine model for CLL. Immunophenotyping and transplant approaches were used to define T-cell subsets at various stages of CLL. Analogous to human CLL, we observed a skewing of T-cell subsets from naive to antigen-experienced memory T cells that was more pronounced in lymph nodes than in blood. Transplantation of CLL into non-transgenic recipients was feasible without immunosuppression in a pure C57BL/6 background and resulted in the prominent skewing of the T cells of the recipient mice. Both in spontaneously developed CLL and in the transplantation setting, a loss in T-cell receptor diversity was observed, with a relevant number of clonal T-cell populations arising. This suggests that antigen-dependent differentiation toward the T memory pool is initiated by murine CLL cells. In summary, we validate the TCL1 transgenic mouse model for analysis of T-cell phenotypes and suggest a CLL-dependent antigen-driven skewing of T cells in these mice.Keywords
This publication has 31 references indexed in Scilit:
- Difference in the Relative Distribution of CD4+ T-cell Subsets in B-CLL With Mutated and Unmutated Immunoglobulin (Ig) VH GenesJournal of Immunotherapy, 2009
- Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulationJournal of Internal Medicine, 2008
- Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?Journal of Clinical Oncology, 2008
- Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drugJCI Insight, 2008
- CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironmentBlood, 2008
- Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cellsBest Practice & Research Clinical Haematology, 2007
- Evolving View of the In-Vivo Kinetics of Chronic Lymphocytic Leukemia B CellsHematology-American Society Hematology Education Program, 2006
- T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the DevilCancer Immunology, Immunotherapy, 2005
- In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsJCI Insight, 2005
- Differential Sensitivity of CD4+ and CD8+T Lymphocytes to the Killing Efficacy of Fas (Apo-1/CD95) Ligand+ Tumor Cells in B Chronic Lymphocytic LeukemiaBlood, 1998